92 related articles for article (PubMed ID: 10509317)
21. Reducing the risk of breast cancer with tamoxifen in women at increased risk.
Vogel VG
J Clin Oncol; 2001 Sep; 19(18 Suppl):87S-92S. PubMed ID: 11560980
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer risks and prevention: implications of the Breast Cancer Prevention Trial results.
Crowell EB; Jubelirer SJ
W V Med J; 2000; 96(6):598-601. PubMed ID: 11194088
[TBL] [Abstract][Full Text] [Related]
23. [Interview with Prof. Dr. Wolfgang Eiermann. Which women need a medicamentous breast cancer prophylaxis?].
Eiermann W
MMW Fortschr Med; 2003 Dec; 145(50):8. PubMed ID: 14963963
[No Abstract] [Full Text] [Related]
24. Stroke risk and tamoxifen therapy for breast cancer.
Geiger AM; Fischberg GM; Chen W; Bernstein L
J Natl Cancer Inst; 2004 Oct; 96(20):1528-36. PubMed ID: 15494603
[TBL] [Abstract][Full Text] [Related]
25. [New prevention strategies against breast cancer and cervical carcinoma. What can you advice to your patients].
Kammerer S
MMW Fortschr Med; 2003 Dec; 145(50):4-6. PubMed ID: 14963962
[No Abstract] [Full Text] [Related]
26. Budget impact analysis of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan.
Kondo M; Hoshi SL; Toi M
Jpn J Clin Oncol; 2009 Nov; 39(11):767-70. PubMed ID: 19656807
[TBL] [Abstract][Full Text] [Related]
27. Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.
Grann VR; Jacobson JS; Whang W; Hershman D; Heitjan DF; Antman KH; Neugut AI
Cancer J Sci Am; 2000; 6(1):13-20. PubMed ID: 10696733
[TBL] [Abstract][Full Text] [Related]
28. The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women.
Bevers TB
J Natl Compr Canc Netw; 2007 Sep; 5(8):719-24. PubMed ID: 17927929
[TBL] [Abstract][Full Text] [Related]
29. Statin use and breast cancer: prospective results from the Women's Health Initiative.
Cauley JA; McTiernan A; Rodabough RJ; LaCroix A; Bauer DC; Margolis KL; Paskett ED; Vitolins MZ; Furberg CD; Chlebowski RT;
J Natl Cancer Inst; 2006 May; 98(10):700-7. PubMed ID: 16705124
[TBL] [Abstract][Full Text] [Related]
30. Tamoxifen for breast cancer prevention: safety warning.
Wooltorton E
CMAJ; 2002 Aug; 167(4):378-9. PubMed ID: 12197698
[No Abstract] [Full Text] [Related]
31. Mimicking pregnancy to reduce breast cancer risk.
Tuma R
J Natl Cancer Inst; 2010 Apr; 102(8):517-8. PubMed ID: 20388876
[No Abstract] [Full Text] [Related]
32. Seven for 2007: seven things you should know about breast cancer risk. There's no big way to reduce your risk for breast cancer, but a combination of approaches could make a difference.
Harv Womens Health Watch; 2007 Jan; 14(5):1-3. PubMed ID: 17304697
[No Abstract] [Full Text] [Related]
33. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
[TBL] [Abstract][Full Text] [Related]
34. [Chemoprevention of breast cancer. Clinical trials in pharmacological prevention].
Ricart JJ
Medicina (B Aires); 2004; 64(1):66-72. PubMed ID: 15034961
[TBL] [Abstract][Full Text] [Related]
35. The pill and ovarian cancer prevention.
Guha M
J Natl Cancer Inst; 2013 Feb; 105(3):154-6. PubMed ID: 23334226
[No Abstract] [Full Text] [Related]
36. Preventing hormone-dependent breast cancer in high-risk women.
Vogel VG; Lo S
J Natl Cancer Inst; 2003 Jan; 95(2):91-3. PubMed ID: 12529335
[No Abstract] [Full Text] [Related]
37. New studies support case for bisphosphonates as possible chemopreventive agent.
Schmidt C
J Natl Cancer Inst; 2010 Apr; 102(7):453-5. PubMed ID: 20339136
[No Abstract] [Full Text] [Related]
38. Breast cancer prevention in the era of precision medicine.
Narod SA
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25855708
[No Abstract] [Full Text] [Related]
39. Breast cancer drugs should be offered to healthy but high risk women, US panel concludes.
McCarthy M
BMJ; 2013 Apr; 346():f2499. PubMed ID: 23599364
[No Abstract] [Full Text] [Related]
40. Tamoxifen reduces breast cancer rate in at-risk healthy women by nearly a third, finds study.
Kmietowicz Z
BMJ; 2014 Dec; 349():g7596. PubMed ID: 25500812
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
